B&S Group

What B&S Group does

B&S Group is a UK-based, family-owned pharmaceutical distribution company operating as a short-line wholesaler to community pharmacies and hospitals. Founded in 1999 by Govind and Samit Hathi as Gowrie Limited and rebranded to B&S (Buying & Selling), the group has run for 25 years and currently serves over 5,000 pharmacies and hospitals daily, with claims of access to 97% of the UK pharmacy market. The company is structured around three operating divisions: B&S Distribution (core short-line pharmaceutical wholesale), B&S Healthcare (parallel imports and unlicensed medicines, holding the largest PI license portfolio in the UK with 1,000+ licenses across 22 European countries), and Gowrie Healthcare (bespoke unlicensed medicines manufacturing, with operations in India).

The technology stack is operationally focused rather than digitally novel. Order capture is multi-channel: direct integration into pharmacy Patient Medication Record (PMR) systems, a proprietary web-based Ordering Platform with 360-degree account management, a Windows Order Pad desktop application, and a dedicated telesales team. Distribution runs on an owned temperature-controlled vehicle fleet delivering daily to 4,000+ sites nationwide with 99% on-time delivery and free next-day delivery for orders before 6 PM. Physical infrastructure includes three UK sites in Perivale (Greenford) and Ruislip (Middlesex), plus a manufacturing office in Vadodara, India. Two material acquisitions — Colorama Pharmaceuticals (2010) and the distribution assets of Waymade PLC (2015) — added parallel import scale and additional UK sites.

The business model is B2B pharmaceutical distribution on transaction-based revenue at market and contract-based pricing. Customers are primarily independent community pharmacies (SMB) with secondary exposure to NHS and private hospitals. The group reports no public revenue or ARR; the only historical figure is £150m in 2002. Ownership remains 100% family-held with no institutional investors, parent company, or public listing, and profits are reinvested into operations, capacity, and selective M&A. Recent strategic emphasis (2020 onwards) has shifted toward quality, regulatory compliance, and operational resilience rather than aggressive expansion.

Name

B&S Group

Legal name

Laxmico Limited t/a B&S Distribution and Gowrie Laxmico Limited t/a B&S Healthcare

Website

https://bnsgroup.co.uk

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

101–250 employees

Short description

B&S Group is a UK-based, family-owned pharmaceutical short-line distributor serving over 5,000 community pharmacies and hospitals daily through its own temperature-controlled fleet. Its three divisions handle generics, parallel imports, and bespoke unlicensed medicines via PMR, web, and desktop ordering channels.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210), Drugs and Druggists' Sundries Merchant Wholesalers (42421), Drugs and Druggists' Sundries Merchant Wholesalers (4242)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Full-Line Pharmaceutical Wholesalers (HLAIAJAA)

akta.pro secondary industries

Specialty Pharmaceutical Distributors (HLAIAJAB), Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor) (HLAIAJAF)

Keywords

• Pharmaceutical distribution
• Parallel imports
• Generic medicines
• Community pharmacy supply
• Cold chain logistics

Headquarters

HQ city

Greenford

HQ country

United Kingdom

HQ region

Europe

Offices8 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Operations, Supply Chain, Personnel, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Pharmaceutical Distribution: Distribution of pharmaceutical products including generics, parallel imports, OTCs, specials, controlled drugs, dressings, and cold chain products to community pharmacies. Revenue generated through product sales with pricing based on market rates and contract terms.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels3 records

Core offering

B&S Group is an integrated pharmaceutical supplier distributing generics, parallel imports, OTC products, specials (unlicensed medicines), controlled drugs, dressings, insulin, and cold-chain products to community pharmacies and hospitals across the UK through its own temperature-controlled delivery fleet. It operates three divisions: B&S Distribution (short-line wholesale), B&S Healthcare (parallel imports with the UK's largest PI license portfolio), and Gowrie Healthcare (bespoke unlicensed medicines manufacturing). Customers place orders through PMR system integration, a web ordering platform, a desktop application, or telesales, with free next-day delivery on orders before 6 PM.

Product overview

B&S Group operates as an integrated pharmaceutical supplier with three main divisions: B&S Distribution (core short-line pharmaceutical wholesale), B&S Healthcare (parallel imports and specials), and Gowrie Healthcare (bespoke unlicensed medicines). The portfolio spans multiple product categories including generics (7M+ packs), parallel imports (1000+ licenses from 22 countries), OTC products (900+ lines), controlled drugs, cold chain, and medical devices. Customers access the offering through multiple platforms: the web-based Ordering Platform, a Windows Order Pad desktop application, PMR system integration, telesales, and email ordering. The company serves over 5,000 community pharmacies and hospitals with daily deliveries.

Differentiator

Problem solved

Functional benefit

Products and services

• B&S Distribution Core short-line pharmaceutical wholesale distribution division, supplying community pharmacies and hospitals across the UK with daily deliveries, temperature-controlled handling, and free next-day delivery for orders placed before 6 PM. Offers over 4,000 stocked products.
• B&S Healthcare (Parallel Imports) Healthcare division specializing in parallel imports of branded medicines sourced from 22 European countries, holding the UK's largest PI license portfolio (over 1,000 MHRA-awarded PI licenses). Provides competitive pricing on hard-to-find and cost-sensitive branded medicines.
• Gowrie Healthcare (Specials Manufacturing) Bespoke manufacturer of unlicensed "specials" medicines produced to exact patient requirements, operating from facilities in the UK and India (Vadodara). Serves pharmacies and clinicians who need formulations outside standard licensed product offerings.
• Generics Product Line

Quantifiable outcome

• 99% on-time delivery rate
• +3 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature4 records

Partnerships

One partnership is on record.

• Colorama PharmaceuticalscoreOthers · 1 January 2010B&S Group acquired the assets of Colorama Pharmaceuticals in 2010 as part of global expansion strategy, enabling the Group to establish offices in London, Oxford, Manchester, Scotland, and India with over 300 employees.

Scale indicators11 records

Recent moves11 records

Expansion highlights5 records

Broad incumbents

• Alliance Healthcare (Walgreens Boots Alliance): One of the largest full-line pharmaceutical wholesalers in the UK and Europe, distributing branded, generic, OTC and healthcare products to pharmacies and hospitals. Direct competitor to B&S on distribution, with a much broader product catalogue and direct manufacturer relationships.
• Phoenix Group: Pan-European pharmaceutical distribution group with a large UK wholesale operation. Competes with B&S across branded and generic wholesale, with greater scale, broader European sourcing, and vertically integrated pharmacy retail interests.
• AAH Pharmaceuticals: A leading UK pharmaceutical wholesaler and part of the McKesson group, distributing across branded, generic and OTC categories. Larger scale than B&S with broader customer reach and supplier negotiating power.

Direct peers

• Sigma Pharmaceuticals: UK pharmaceutical distributor supplying generics, parallel imports, branded medicines and OTCs to independent pharmacies. Direct peer to B&S in short-line wholesale with similar focus on community pharmacy customers.
• Mawdsleys: UK-based short-line pharmaceutical distributor supplying generics, parallel imports, specials, and a wide product range to independent community pharmacies. Closely comparable business model, customer base, and product mix to B&S Group.
• Waymade PLC: UK pharmaceutical distribution and parallel import specialist, of which B&S Group acquired the distribution assets in 2015. Historically a direct peer in the PI market and a relevant benchmark for the segment B&S now operates in.
• Lexon (UK) Limited: UK short-line pharmaceutical wholesaler offering parallel imports, generics, OTCs, and specials to independent pharmacies. Direct competitor to B&S in the same short-line segment, with overlapping product categories and customer types.
• Target Healthcare: UK-based pharmaceutical distributor focused on parallel imports, generics and unlicensed medicines for community pharmacy. Direct peer in the same short-line / PI-led segment, competing for the same independent pharmacy customers.

Emerging players

• Trident Pharmaceuticals: Smaller UK pharmaceutical wholesaler focused on generics and parallel imports to community pharmacies. Comparable product mix and customer profile to B&S, though at a smaller scale.
• OTC Direct: UK wholesaler of OTC, consumer healthcare and pharmacy products, including parallel imports. Overlaps with B&S in OTC and PI lines and serves a similar community pharmacy customer base, albeit with a more consumer-health focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/bnsgroup_uk
• Facebookfacebook.com/bnsgroup.pharmaceuticals
• LinkedInlinkedin.com/company/gowrie-healthcare-private-ltd.

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about B&S Group